New Health Sciences develops a technology to extend the shelf life of refrigerated red blood cells using novel storage methods.
Business Model:
Revenue: $0
Employees: 11-50
Address:
City: Lexington
State: Massachusetts
Zip:
Country: United States
New Health Sciences is developing Hemanext, a technology designed to improve the safety and efficacy of transfusion therapy through novel storage methods potentially extending the shelf life of refrigerated red blood cells while improving their quality across the storage cycle. NHSi has financed development of the Hemanext technology through private investor funding and a series of NIH SBIR grants.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 12/2017 | Venture Round | 1 | $2.7M |
National Institutes of Health National Institutes of Health |
9/2021 | Series A | 1 | $15M |
Omega Advisors Omega Advisors |
10/2019 | Venture Round | $21.2M | 12/2013 | Venture Round | $12.3M |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|